Global Non-invasive Prenatal Testing Market 2017-2021

Overview of the global non-invasive prenatal testing market

The invasive methods of prenatal testing can cause miscarriages and are painful. This resulted in the development of non-invasive prenatal testing (NIPT) through advancements in genomic sciences and bioinformatic analytical tools. NIPT was introduced in the year 2011. This enabled physicians to carry out a safe screening and detection of chromosomal abnormalities in fetuses. Research analysis on the global non-invasive prenatal testing market identifies that the growing preference for non-invasive methods over invasive methods will be one of the major factors that will have a positive impact on the growth of the market. NIPT reduces the number of false-positive results. NIPT will continue to gain popularity because it does not require trained healthcare professionals to conduct the test. Technavio’s market research analysts predict that this market will grow at a CAGR of close to 17% by 2021.

The awareness about NIPT is increasing among people due to the rising penetration of the Internet in the Americas. This results in an increased effort on preventing anomalies in infants. According to the studies, the rate of advanced maternal age (AMA) in the US is more than 9% for first-time mothers. The increasing maternal age drives the risk of chromosomal abnormalities. This encourages the health-conscious mothers in the region to adopt NIPT. Furthermore, the growing awareness and increasing number of genetic tests performed in the countries such as the US, Brazil, Canada, and Mexico will boost the demand for NIPT.

Competitive landscape and key vendors